Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dyslipidemia

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 34 articles: HTML format

Single Articles

September 2026
1. BERRY ASF, Cawley D, Hattenberger A, Chang AR, et al
   Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia: A Population-Based Cohort Study.
   J Am Coll Cardiol. 2026;88:1093-1103.
   PubMed     Abstract available
   
   
   July 2026
2. RIKHI R, Chen H, Mirzai S, Bhatia HS, et al
   The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association's PREVENT Calculator: Insights From MESA.
   J Am Coll Cardiol. 2026 Jul 7:S0735-1097(26)06707.
   PubMed     Abstract available
   
   
   June 2026
3. GONG J, Chiu N, Clinch KA, Qian Y, et al
   Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome.
   J Am Coll Cardiol. 2026 Jun 17:S0735-1097(26)06350.
   PubMed     Abstract available
   
   
   
4. KHAN SS, Ndumele CE, Bhave N, Blumenthal RS, et al
   Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Ca
   J Am Coll Cardiol. 2026 Jun 9:S0735-1097(26)06493.
   PubMed     Abstract available
   
   
   May 2026
5. RAY KK, Clarke N, Thornton P, Miles AE, et al
   Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk.
   J Am Coll Cardiol. 2026 May 26:S0735-1097(26)06570.
   PubMed     Abstract available
   
   
   
6. BLUMENTHAL RS, Morris PB, Gaudino M, Johnson HM, et al
   2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
   J Am Coll Cardiol. 2026;87:2624-2757.
   PubMed     Abstract available
   
   
   April 2026
7. MISRA A, Jowell A, Haidermota S, Perez E, et al
   Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions.
   J Am Coll Cardiol. 2026 Apr 29:S0735-1097(26)05809.
   PubMed     Abstract available
   
   
   March 2026
8. KNUDSEN AD, Kuhl JT, Schultz NA, Villadsen GE, et al
   Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls: A Nationwide Study Using Protocolized CT Angiography.
   J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00207.
   PubMed     Abstract available
   
   
   November 2025
9. LEE HH, Crawford EB, Cho SMJ, Krawisz AK, et al
   Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023.
   J Am Coll Cardiol. 2025 Nov 26:S0735-1097(25)09917.
   PubMed     Abstract available
   
   
   September 2025
10. BLAIS JE, Yan VKC, Chan EWY, Wong ICK, et al
    Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes: An Emulation.
    J Am Coll Cardiol. 2025;86:797-809.
    PubMed     Abstract available
    
    
    
11. AMBROSY AP, Daida YG, Parikh RV, Tan TC, et al
    Incidence of Heart Failure in Asian American, Native Hawaiian, and Other Pacific Islander Populations.
    J Am Coll Cardiol. 2025;86:725-734.
    PubMed     Abstract available
    
    
    August 2025
12. NICHOLLS SJ, Nelson AJ, Ray KK, Ballantyne CM, et al
    Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07383.
    PubMed     Abstract available
    
    
    June 2025
13. KOREN MJ, Vega RB, Agrawal N, Xu Y, et al
    An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial.
    J Am Coll Cardiol. 2025;85:1996-2007.
    PubMed     Abstract available
    
    
    May 2025
14. NORDESTGAARD AT, Tybjaerg-Hansen A, Mansbach H, Kersten S, et al
    Target Populations for Novel Triglyceride-Lowering Therapies.
    J Am Coll Cardiol. 2025;85:1876-1897.
    PubMed     Abstract available
    
    
    
15. XIE X, Shi X, Zhang Y, Su S, et al
    Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study.
    J Am Coll Cardiol. 2025;85:1821-1835.
    PubMed     Abstract available
    
    
    
16. RAY KK, Linnebjerg H, Michael LF, Shen X, et al
    Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies.
    J Am Coll Cardiol. 2025;85:1803-1818.
    PubMed     Abstract available
    
    
    
17. BALLANTYNE CM, Gaudet D, Rosenson RS, Hegele RA, et al
    Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia.
    J Am Coll Cardiol. 2025;85:1839-1854.
    PubMed     Abstract available
    
    
    November 2024
18. SUN Y, Lv Q, Guo Y, Wang Z, et al
    Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial.
    J Am Coll Cardiol. 2024;84:2037-2047.
    PubMed     Abstract available
    
    
    
19. XU M, Wang Z, Zhang Y, Liu Y, et al
    Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial.
    J Am Coll Cardiol. 2024;84:2026-2036.
    PubMed     Abstract available
    
    
    September 2024
20. TOTH PP
    Triglycerides and Cardiovascular Risk: Getting to the Heart of the Matter.
    J Am Coll Cardiol. 2024;84:1007-1009.
    PubMed    
    
    
    April 2024
21. WRIGHT RS, Leiter LA, Lesogor A, Ray KK, et al
    Reply: Evaluation of the Inclisiran Safety in High-Risk Populations.
    J Am Coll Cardiol. 2024;83:e129.
    PubMed    
    
    
    
22. JIANG X, Zhang Z, Ding H
    Evaluation of the Inclisiran Safety in High-Risk Populations.
    J Am Coll Cardiol. 2024;83:e127.
    PubMed    
    
    
    March 2024
23. SZAREK M, Bhatt DL, Miller M, Brinton EA, et al
    Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
    J Am Coll Cardiol. 2024 Mar 15:S0735-1097(24)00384.
    PubMed     Abstract available
    
    
    
24. BLAHA MJ, Bhatia HS
    Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy.
    J Am Coll Cardiol. 2024 Mar 9:S0735-1097(24)00944.
    PubMed    
    
    
    December 2023
25. BALLANTYNE CM, Minhas AMK, Orringer CE
    Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of siRNA Therapies for Prevention?
    J Am Coll Cardiol. 2023;82:2262-2264.
    PubMed    
    
    
    
26. WRIGHT RS, Koenig W, Landmesser U, Leiter LA, et al
    Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials.
    J Am Coll Cardiol. 2023;82:2251-2261.
    PubMed     Abstract available
    
    
    October 2023
27. GIDDING SS
    Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:1558-1563.
    PubMed     Abstract available
    
    
    August 2023
28. BEN-YEHUDA O
    Combination Therapy With Lower Statin Dose and the Race to LDL-C Goal: A Clear Winner?
    J Am Coll Cardiol. 2023;82:411-413.
    PubMed    
    
    
    
29. LEE SJ, Joo JH, Park S, Kim C, et al
    Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2023;82:401-410.
    PubMed     Abstract available
    
    
    July 2023
30. KALRA DK, Vorla M, Michos ED, Agarwala A, et al
    Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:171-181.
    PubMed     Abstract available
    
    
    
31. MORALES J, Handelsman Y
    Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:161-170.
    PubMed     Abstract available
    
    
    May 2023
32. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    PubMed     Abstract available
    
    
    April 2023
33. CHOI D, Malick WA, Koenig W, Rader DJ, et al
    Familial Hypercholesterolemia: Challenges for a High-Risk Population: JACC Focus Seminar 1/3.
    J Am Coll Cardiol. 2023;81:1621-1632.
    PubMed     Abstract available
    
    
    
34. BALLANTYNE CM, Banka P, Mendez G, Garcia R, et al
    Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616.
    J Am Coll Cardiol. 2023;81:1553-1564.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum